1.
MYCOSES : Surveillance épidémiologique en Belgique 2016-2017
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples ...
2.
3.
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples (March – October 2020) ...
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium – a serial prospective cross-sectional nationwide study of residual samples (March – October 2020)
Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method
A 5-year survey of dermatophytes strains circulating in Belgium
Epidemiology and clinical reporting of candidaemia in Belgium : a national prospective study (TANSIR trial) ; Epidémiologie et aspects cliniques des candidémies en Belgique: étude...
4.
5.
Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital
Seroprevalence of IgG antibodies against SARS-CoV-2-a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020
